BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 63 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $653 | -18.8% | 628 | 0.0% | 0.00% | – |
| Q2 2023 | $804 | -95.1% | 628 | -94.7% | 0.00% | – |
| Q1 2023 | $16,374 | +1479.0% | 11,780 | +1376.2% | 0.00% | – |
| Q4 2022 | $1,037 | +3.7% | 798 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -92.3% | 798 | -86.8% | 0.00% | – |
| Q2 2022 | $13,000 | -55.2% | 6,026 | -44.2% | 0.00% | – |
| Q1 2022 | $29,000 | -89.9% | 10,791 | -81.7% | 0.00% | – |
| Q4 2021 | $288,000 | +9.9% | 58,912 | +184.4% | 0.00% | – |
| Q3 2021 | $262,000 | +63.8% | 20,717 | +101.0% | 0.00% | – |
| Q2 2021 | $160,000 | -73.7% | 10,306 | -44.2% | 0.00% | – |
| Q1 2021 | $608,000 | – | 18,476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $29,242,000 | 11.52% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $18,041,000 | 5.60% |
| Novo Holdings A/S | 4,503,991 | $69,632,000 | 3.09% |
| Vivo Capital, LLC | 3,871,291 | $59,850,000 | 2.59% |
| Sofinnova Investments, Inc. | 2,754,437 | $42,584,000 | 2.45% |
| Ally Bridge Group (NY) LLC | 412,267 | $6,374,000 | 1.58% |
| Samsara BioCapital, LLC | 737,459 | $11,401,000 | 1.41% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $11,125,000 | 1.04% |
| RA Capital Management | 2,378,325 | $36,769,000 | 0.59% |
| Rock Springs Capital Management LP | 1,619,248 | $25,034,000 | 0.50% |